美國居民不適用 XM 服務。
C
C

CSX

技術摘要

指標價值趨勢
指標價值趨勢
指標價值趨勢
指標S3S2S1PR1R2R3

財經新聞

Canada railways warn of Aug. 22 lockout without labor deal

UPDATE 4-Canada railways warn of Aug. 22 lockout without labor deal Adds request by CN for federal intervention, comments from union paragraphs 1, 4-5, 8 OTTAWA, Aug 9 (Reuters) - C anada's two main rail companies said on Friday they would lock out employees on Aug. 22 if talks to negotiate a labor contract fail , a move that would bring the country's transport of goods to a halt .
C

U.S. STOCKS Lumen Technologies, Broadridge Financial, IDEXX

BUZZ-U.S. STOCKS ON THE MOVE-Lumen Technologies, Broadridge Financial, IDEXX Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes rose over 1% on Tuesday, as investors looked for bargains after a global stock selloff and dovish comments from Federal Reserve officials lifted market sentiment.
A
A
B
C
I
U
U
F
M
R
T
U
B
J
M

CSX rises after Q2 profit tops expectations

BUZZ-CSX rises after Q2 profit tops expectations ** CSX Corp's CSX.O shares up 2% at $33.67 premarket after U.S. railroad operator's qtrly earnings surpass expectations ** Q2 adj EPS of 49 cents beat consensus by a penny, per LSEG, as co benefited from higher shipment volumes, robust pricing ** Rev of $3.7 bln in qtr inline with Street ** JP Morgan, which rates CSX "overweight", boosted its PT by $3 to $42 ** CSX will outperform rail peers after Q2 results were "significantly better than expecte
C
U

U.S. Actinium, Albemarle, ArcBest

U.S. RESEARCH ROUNDUP- Actinium, Albemarle, ArcBest Aug 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Actinium Pharmaceuticals, Albemarle and ArcBest, on Tuesday. HIGHLIGHTS * Actinium Pharmaceuticals Inc ATNM.A : JonesTrading cuts PT to $9 from $26 * Albemarle ALB.N : Baird cuts to neutral; cuts target price to $85 from $102 * ArcBest Corp ARCB.O : Stephens cuts target price to $130 from $145 * Crispr Therapeuti
A
A
B
B
C
C
C
C
D

CSX beats second-quarter profit on better volumes, strong pricing

CSX beats second-quarter profit on better volumes, strong pricing Aug 5 (Reuters) - U.S. railroad operator CSX CSX.O narrowly beat second-quarter profit estimates on Monday, helped by higher shipment volumes and robust pricing, sending its shares up 5% after the bell. Improving intermodal volumes, or goods moved via two or more modes of transport, have helped railroads squeeze out profits along with higher-than-inflation pricing, even as the overall freight industry continues to face a downturn.
C

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明